Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.

MLA

Dulai, Parambir S., et al. “Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 18, no. 13, Dec. 2020, p. 2952. EBSCOhost, https://doi.org/10.1016/j.cgh.2020.02.010.

APA

Dulai, P. S., Singh, S., Vande Casteele, N., Meserve, J., Winters, A., Chablaney, S., Aniwan, S., Shashi, P., Kochhar, G., Weiss, A., Koliani-Pace, J. L., Gao, Y., Boland, B. S., Chang, J. T., Faleck, D., Hirten, R., Ungaro, R., Lukin, D., Sultan, K., … Cao, C. (2020). Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 18(13), 2952. https://doi.org/10.1016/j.cgh.2020.02.010

Chicago

Dulai, Parambir S, Siddharth Singh, Niels Vande Casteele, Joseph Meserve, Adam Winters, Shreya Chablaney, Satimai Aniwan, et al. 2020. “Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 18 (13): 2952. doi:10.1016/j.cgh.2020.02.010.